Barnaby Balmforth

Barnaby has more than 10 years’ experience in the leadership of genomic technology development. Prior to co-founding Biofidelity he was Chief Operating Officer and Board member at Base4 as well as leading the development of the company’s molecular biology. Barnaby holds a PhD from the University of Cambridge and a Masters from the University of Oxford.